Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 12/2007

01-12-2007 | Letter to the Editor

Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation

Authors: Mathias Witzens-Harig, Rüdiger Waldherr, Joerg Beimler, Martin Zeier, Jochen Hansmann, Anthony D. Ho, Hartmut Goldschmidt, Thomas Moehler

Published in: Annals of Hematology | Issue 12/2007

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842–854PubMedCrossRef
2.
Greipp PR, San MJ, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412–3420PubMedCrossRef
3.
Ronco P, Aucouturier P, Mougenot B (2000) Plasma cell dyscrasia- related glomerulopathies and Fanconi’s syndrome: a molecular approach. J Nephrol 13(suppl 3):S34–S44PubMed
4.
Santostefano M, Zanchelli F, Zaccaria A, Poletti G, Fusaroli M (2005) The ultrastructural basis of renal pathology in monoclonal gammopathies. J Nephrol 18:659–675PubMed
5.
Schwartz MM, Korbet SM, Lewis EJ (2002) Immunotactoid glomerulopathy. J Am Soc Nephrol 13(5):1390–1397, Review. MayPubMedCrossRef
6.
Sturgil BC, Bolton WK (1989) Non-amyloidotic fibrillary glomerulopathy. Kidney Int 35:233
7.
Korbet SM, Rosenberg BF, Schwartz MM, Lewis EJ (1990) Course of renal transplantation in immunotactoid glomerulopathy. Am J Med 89:91–95PubMedCrossRef
8.
Alpers CE, Rennke HG, Hopper J, Biava CG (1987) Fibrillary glomerulonephritis: An entity with unusual immunofluorescence features. Kidney Int 31:781–789PubMedCrossRef
9.
Pronovost PH, Brady HR, Gunning ME, Espinoza O, Rennke HG (1996) Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy. [Review]. Nephrol Dial Transplant 11:837–842PubMed
10.
Korbet SM, Schwartz MM, Rosenberg BF, Sibley RK, Lewis EJ (1985) Immunotactoid glomerulopathy. Medicine (Baltimore) 64:228–243
11.
Iskandar SS, Falk RJ, Jennette JC (1992) Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 42:1401–1407PubMedCrossRef
12.
Schonland SO, Perz JB, Hundemer M, Hegenbart U, Kristen AV, Hund E, Dengler TJ, Beimler J, Zeier M, Singer R, Linke RP, Ho AD, Goldschmidt H (2005) Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis. Transplantation 80(1 Suppl):S160–S163, Sep 27PubMedCrossRef
Metadata
Title
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation
Authors
Mathias Witzens-Harig
Rüdiger Waldherr
Joerg Beimler
Martin Zeier
Jochen Hansmann
Anthony D. Ho
Hartmut Goldschmidt
Thomas Moehler
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 12/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0330-6

Other articles of this Issue 12/2007

Annals of Hematology 12/2007 Go to the issue

Letter to the Editor

Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA)

Letter to the Editor

Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma

Letter to the Editor

Severe intestinal vasculitis in a patient under treatment with bortezomib

Letter to the Editor

Rituximab in autoimmune pancytopenia: a case report and review of literature

Original Article

Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi

Letter to the Editor

Refractory multiple myeloma treated with homoharringtonine: report of two cases
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits